KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Sales (2016 - 2025)

Historic Return on Sales for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to 14.61%.

  • Arbutus Biopharma's Return on Sales rose 1200.0% to 14.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.89%, marking a year-over-year increase of 84800.0%. This contributed to the annual value of 11.33% for FY2024, which is 73100.0% down from last year.
  • As of Q3 2025, Arbutus Biopharma's Return on Sales stood at 14.61%, which was up 1200.0% from 0.23% recorded in Q2 2025.
  • In the past 5 years, Arbutus Biopharma's Return on Sales ranged from a high of 0.23% in Q2 2025 and a low of 14.73% during Q3 2024
  • In the last 5 years, Arbutus Biopharma's Return on Sales had a median value of 6.65% in 2021 and averaged 6.88%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -104100bps in 2024, then soared by 117000bps in 2025.
  • Arbutus Biopharma's Return on Sales (Quarter) stood at 6.65% in 2021, then skyrocketed by 47bps to 3.51% in 2022, then plummeted by -156bps to 9.0% in 2023, then increased by 12bps to 7.94% in 2024, then tumbled by -84bps to 14.61% in 2025.
  • Its Return on Sales stands at 14.61% for Q3 2025, versus 0.23% for Q2 2025 and 13.91% for Q1 2025.